Swiss biopharma giant Novartis announced Monday it plans to buy Seattle-based Chinook Therapeutics for $3.2 billion, marking another blockbuster acquisition for the biotech industry in the Seattle region. Founded in… Read More
— Seattle vaccine maker Curevo Vaccine hired Guy De La Rosa as its new chief medical officer. De La Rosa was previously an executive director at Enanta Pharmaceuticals, where he… Read More
Here’s a rundown of the top life sciences and health news across the Pacific Northwest this week. Seagen CEO resigns after domestic violence arrest: Clay Siegall resigned as CEO and… Read More
This week we highlighted the finalists for Health Innovation of the Year at the GeekWire Awards. The finalists showcase the strength of science and innovation in the Pacific Northwest. That… Read More
The news: Chinook Therapeutics on Tuesday announced the formation of SanReno Therapeutics, which will advance therapies for kidney disease in China, Hong Kong, Macau, Taiwan and Singapore. SanReno is a… Read More
Chinook Therapeutics, a Vancouver, B.C.-based biotech company creating targeted therapies for kidney diseases, raised $65 million in a Series A financing round led by Versant Ventures with Apple Tree Partners… Read More